All 1 tracked stories fall under one category: pharma. Bloomage Biotechnology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Shanghai Haohai Biological Technology Co., Ltd appears in 1 tracked Biotech story from March 21, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Shanghai Haohai Biological Technology Co., Ltd
All 1 tracked stories fall under one category: pharma. Bloomage Biotechnology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Shanghai Haohai Biological Technology Co., Ltd appears in 1 tracked Biotech story from March 21, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Shanghai Haohai Biological Technology Co., Ltd. Shared-story counts are live from our verified record — not editorial picks.
Shanghai Haohai Biological Technology Co., Ltd. has reported a decline in full-year income for the 2025 fiscal year, driven by margin compression in its core ophthalmology and orthopedic segments. The retreat highlights the ongoing challenges of China's volume-based procurement (VBP) policies and intensifying competition in the medical aesthetics market.
Shanghai Haohai Biological Technology Co., Ltd is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.